Here, KLK15 mRNA levels were found to be significantly higher in cancerous tissues compared with benign tumors and, furthermore, elevated KLK15 expression levels were associated with both reduced progression-free and overall survival. This evidence concerns the gene KLK15 and benign neoplasm.